• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Performance of a Short Version of the Everyday Cognition Scale (ECog-12) to Detect Cognitive Impairment.日常认知量表(ECog-12)短版检测认知障碍的性能。
J Prev Alzheimers Dis. 2024;11(6):1741-1750. doi: 10.14283/jpad.2024.109.
2
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
3
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
4
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
5
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
6
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
7
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
8
Folic acid with or without vitamin B12 for cognition and dementia.叶酸联合或不联合维生素B12对认知及痴呆的影响
Cochrane Database Syst Rev. 2003(4):CD004514. doi: 10.1002/14651858.CD004514.
9
Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health Registry.在大脑健康登记处的无监督在线环境中,主观认知能力下降可预测纵向神经心理学测试表现。
Alzheimers Res Ther. 2025 Jan 7;17(1):10. doi: 10.1186/s13195-024-01641-2.
10
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.

引用本文的文献

1
Evaluating the Accuracy of Web-Based and In-Clinic Subjective Cognitive Decline Assessments in Detecting Cognitive Impairment: Multicohort Study.评估基于网络和临床主观认知衰退评估在检测认知障碍方面的准确性:多队列研究。
J Med Internet Res. 2025 Aug 11;27:e69689. doi: 10.2196/69689.
2
Hepatic encephalopathy predicts early post-transplant cognitive and functional impairment: The Livcog cohort study.肝性脑病预示移植后早期认知和功能障碍:Livcog队列研究。
Hepatol Commun. 2025 Apr 3;9(4). doi: 10.1097/HC9.0000000000000696. eCollection 2025 Apr 1.

本文引用的文献

1
Lecanemab: Appropriate Use Recommendations.仑卡奈单抗:合理使用建议。
J Prev Alzheimers Dis. 2023;10(3):362-377. doi: 10.14283/jpad.2023.30.
2
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.增加 AD 研究中的参与者多样性:在阿尔茨海默病神经影像学倡议 4 中进行数字筛查、血液检测和社区参与方法的计划。
Alzheimers Dement. 2023 Jan;19(1):307-317. doi: 10.1002/alz.12797. Epub 2022 Oct 9.
3
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.多种血浆 Aβ42 和 Aβ40 分析物的比较分析性能及其预测正电子发射断层扫描淀粉样蛋白阳性的能力。
Alzheimers Dement. 2023 Mar;19(3):956-966. doi: 10.1002/alz.12697. Epub 2022 Jul 12.
4
Validity of Online Versus In-Clinic Self-Reported Everyday Cognition Scale.在线与门诊自我报告日常认知量表的有效性。
J Prev Alzheimers Dis. 2022;9(2):269-276. doi: 10.14283/jpad.2022.20.
5
Association of Subjective Memory Complaints With White Matter Hyperintensities and Cognitive Decline Among Older Adults in Chicago, Illinois.伊利诺伊州芝加哥市老年人主观记忆主诉与脑白质高信号和认知能力下降的相关性研究。
JAMA Netw Open. 2022 Apr 1;5(4):e227512. doi: 10.1001/jamanetworkopen.2022.7512.
6
Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments.测量老年人的主观认知下降:认知变化指数与日常认知工具测量之间的协调。
J Alzheimers Dis. 2022;87(2):761-769. doi: 10.3233/JAD-215388.
7
The Prevalence of Amnestic and Non-Amnestic Mild Cognitive Impairment and Its Association with Different Lifestyle Factors in a South Italian Elderly Population.意大利南部老年人群遗忘型和非遗忘型轻度认知障碍的患病率及其与不同生活方式因素的关系。
Int J Environ Res Public Health. 2022 Mar 6;19(5):3097. doi: 10.3390/ijerph19053097.
8
Self-reported subjective cognitive decline is associated with global cognition in a community sample of Latinos/as/x living in the United States.居住在美国的拉丁裔人群中,自我报告的主观认知能力下降与整体认知能力相关。
J Clin Exp Neuropsychol. 2021 Sep;43(7):663-676. doi: 10.1080/13803395.2021.1989381. Epub 2021 Oct 28.
9
Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer's disease.早发性阿尔茨海默病患者的纵向脑萎缩与脑脊液生物标志物。
Neuroimage Clin. 2021;32:102804. doi: 10.1016/j.nicl.2021.102804. Epub 2021 Aug 25.
10
Subjective cognitive decline and objective cognition among diverse U.S. Hispanics/Latinos: Results from the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).美国不同族裔的西班牙裔/拉丁裔人群中的主观认知下降与客观认知:来自拉丁裔神经认知老化研究(SOL-INCA)的结果。
Alzheimers Dement. 2022 Jan;18(1):43-52. doi: 10.1002/alz.12381. Epub 2021 May 31.

日常认知量表(ECog-12)短版检测认知障碍的性能。

Performance of a Short Version of the Everyday Cognition Scale (ECog-12) to Detect Cognitive Impairment.

机构信息

Rachel L. Nosheny, Ph.D., Assistant Professor, University of California, San Francisco, Department of Psychiatry, San Francisco VA Medical Center, 4150 Clement Street (114M), San Francisco, CA 94121, Tel: 650-468-0619, Fax: 415-668-2864, email:

出版信息

J Prev Alzheimers Dis. 2024;11(6):1741-1750. doi: 10.14283/jpad.2024.109.

DOI:10.14283/jpad.2024.109
PMID:39559885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11573828/
Abstract

BACKGROUND

The Everyday Cognition (ECog) 12-item scale, a functional decline measurement, can distinguish dementia from cognitively unimpaired (CU). Limited data compare ECog-12 performance by raters (self vs. informant) and scoring systems (average numeric vs. categorical grouping) to differentiate cognitive statuses.

OBJECTIVES

To evaluate the performance of ECog-12 in differentiation cognitive statuses.

DESIGN

A cross-sectional diagnostic test study.

SETTING AND PARTICIPANTS

Data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study are analyzed. Participants were aged 55-90 years old divided into subgroups based on diagnostic criteria.

MEASUREMENTS

We evaluated ECog-12 performance across different diagnostic groups, such as CU vs cognitive impairment (CI; mild cognitive impairment (MCI), and dementia), and the association between ECog-12 and CI. This procedure was repeated for self- and partner (informant)-reports. Additionally, types of ECog scores were also assessed, where an average ECog score was calculated (continuous numeric) as well as a categorical grouping ("any occasional declined" or "any consistently declined") based on item-level responses to ECog questions.

RESULTS

ECog-12 cut-off scores of 1.36 (self-reported) and 1.45 (partner-reported) distinguish CU from CI with AUC 0.7 and 0.78, respectively. Adding a memory-concern question improved self-reported-ECog AUC to 0.79. Self- and partner-reported "consistently-declined" ECog-12 categorical grouping provided AUC 0.69 and 0.78. The study partner reported ECog-12 showed a greater association with CI than self-reported, with odds ratios of 35.45 and 8.79, respectively.

CONCLUSION

Study partner-reported ECog scores performed better than self-reported ECog-12 in differentiating cognitive statuses, and a higher study partner reported ECog score was a higher prognostic risk for CI. A memory concern question could enhance self-reported ECog-12 performance. This further emphasizes the need to obtain data from study partners for research and clinical practice.

摘要

背景

日常认知(ECog)12 项量表是一种衡量功能下降的方法,可以将痴呆与认知正常(CU)区分开来。目前关于评估者(自我报告与知情者报告)和评分系统(平均数值与分类分组)对 ECog-12 表现的比较数据有限,这些数据可用于区分认知状态。

目的

评估 ECog-12 在区分认知状态方面的性能。

设计

一项横断面诊断测试研究。

地点和参与者

分析来自阿尔茨海默病神经影像学倡议(ADNI)研究的数据。参与者年龄在 55-90 岁之间,根据诊断标准分为亚组。

测量方法

我们评估了 ECog-12 在不同诊断组中的表现,例如 CU 与认知障碍(CI;轻度认知障碍(MCI)和痴呆),以及 ECog-12 与 CI 之间的相关性。这一过程在自我报告和伴侣(知情者)报告中重复进行。此外,还评估了 ECog 评分的类型,包括计算 ECog 的平均得分(连续数值)以及根据 ECog 问题的项目水平回答进行分类分组(“偶尔下降”或“持续下降”)。

结果

ECog-12 的截断值为 1.36(自我报告)和 1.45(伴侣报告),分别用于区分 CU 与 CI,曲线下面积(AUC)分别为 0.7 和 0.78。添加记忆问题可将自我报告的 ECog-AUC 提高至 0.79。自我报告和伴侣报告的“持续下降”ECog-12 分类分组的 AUC 分别为 0.69 和 0.78。与自我报告相比,研究伴侣报告的 ECog-12 与 CI 的相关性更强,优势比分别为 35.45 和 8.79。

结论

研究伴侣报告的 ECog 评分在区分认知状态方面优于自我报告的 ECog-12,且研究伴侣报告的 ECog 评分越高,CI 的预后风险越高。添加记忆问题可提高自我报告的 ECog-12 表现。这进一步强调了在研究和临床实践中需要从研究伴侣那里获取数据。